Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
8M
-
Shares change
-
+4.87M
-
Total reported value, excl. options
-
$34M
-
Value change
-
+$22.2M
-
Put/Call ratio
-
1.28
-
Number of buys
-
40
-
Number of sells
-
-12
-
Price
-
$4.25
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2022
66 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q4 2022.
Summit Therapeutics Inc. - COM (SMMT) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2M shares), VANGUARD GROUP INC (1.44M shares), MARSHALL WACE, LLP (623K shares), BlackRock Inc. (535K shares), GEODE CAPITAL MANAGEMENT, LLC (472K shares), Steward Partners Investment Advisory, LLC (305K shares), AWM Investment Company, Inc. (300K shares), TWO SIGMA INVESTMENTS, LP (286K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (280K shares), and BOOTHBAY FUND MANAGEMENT, LLC (221K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.